The April 2010 issue of the Journal of Commercial Biotechnology is now available. The links below will take you to the abstract for each paper:
Volume 16, Issue 2
Editorial
| Case studies in innovation: What enables outstanding achievements? | |
| Yali Friedman |
Articles
| Biotechnology marketing: Insider and outsider views | |
| Päivi Eriksson, Heidi Rajamäki |
| The current M&A environment and its strategic implications for emerging biotherapeutics companies | |
| Mohan Sowlay, Scott Lloyd |
| Practical approaches to early stage life sciences technology valuations | |
| Stephen Mayhew |
| Commercializing synthetic biology: Socio-ethical concerns and challenges under intellectual property regime | |
| Trichi Saukshmya, Archana Chugh |
| From carbon to carbohydrates: Corporate strategies for biopolymer technology development | |
| Avrath Chadha |
| Biotechnology in the capital region of Europe | |
| Jan Wauters |
Legal and Regulatory Updates
| Legal and regulatory update | |
| Gerry Kamstra, John Wilkinson |
Conference Report
| Funding the dream at the Mid-Atlantic Biotech Conference | |
| Harley King |
Book Reviews
| Book Review: Getting to Plan B: Breaking through to a better business model | |
| Arlen D Meyers |
| Book Review: Driving innovation – Intellectual property strategies for a dynamic world | |
| Barry J Marenberg |
| Book Review: Intellectual property, medicine and health: Current debates | |
| Stanley P Kowalski |
Bird & Bird